GSK

three triple doors opportunity cracked open ajar
Biotech

GSK picks 1st biotech partners under $7B Flagship pact

Notably, Profound and Quotient are the two biotechs Pfizer has also chosen to work with in a separate VC-pharma collaboration.
Gabrielle Masson Nov 20, 2025 6:30am
Three blocks displaying from left to right a person a handshake and another person

GSK pens $50M pact to join Big Pharma peers in emerging modality

Nov 19, 2025 4:40am
Martin Makary FDA Senate HELP confirmation

FDA reveals 2nd round of 'national priority' voucher winners

Nov 6, 2025 3:12pm
GSK ESMO

GSK loses hope for CD226 cancer therapies, dropping ph. 2 assets

Oct 29, 2025 6:29am
Lung

GSK pens $750M deal for COPD-focused oligonucleotide in phase 1

Oct 28, 2025 6:45am
GSK ESMO

GSK pens $357M pact with French biotech for prostate cancer ADC

Oct 27, 2025 4:07am